Treating everyone 60 and older with early hypertension cost-effective

Reuters Health - 08/01/2021 - Treating stage-1 hypertension (blood pressure 140-159/90-99 mm Hg) in everyone over age 60 is cost-effective, even in low-risk individuals (<10-year cardiovascular disease risk), a modeling study suggests. "These findings contributed to the change in UK practice suggested in the latest NICE guidelines on management of hypertension (NG136; https://bit.ly/2L5j8hR) for individuals without established cardiovascular disease where risk scoring is used," Dr. Anthony Wierzbicki of Guy's and St. Thomas' Hospitals in London, UK, told Reuters Health by email. "In the U.S., where the cardiovascular risk score system is slightly different, they provide general support for the lower thresholds suggested in the AHA-ACC guidelines for management of cardiovascular disease," he said. "The European Score risk calculation system is very different to UK QRISK or U.S. ASCVD scores, but the general principle of intervention at lower risk than previously c...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 8 January, 202118 January, 2021